
6.74 Delayed Data As of May 16 | ![]() Today’s Change | 4.98 Today|||52-Week Range 65.33 | -59.59% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $977.0M |
BridgeBio Pharma, Inc. 421 Kipling Street Palo Alto California 94301 |
Neil Kumar | Chief Executive Officer & Director |
Christine E. Siu | Chief Operating Officer |
Brian C. Stephenson | Chief Financial Officer & Secretary |
Uma Sinha | Chief Scientific Officer |
Richard H. Scheller | Director, Chairman-Research & Development |